World-Class Testing and Groundbreaking Research Translate into Better Care
Experts, Available to Serve
The Providence Molecular Genomics Laboratory (MGL) was developed to serve the unique needs of Providence providers, researchers, and collaborators.
Deep Molecular Genomics Expertise
The MGL leverages its deep expertise in genomics, molecular pathology, and computational biology/bioinformatics to provide state-of-art support for care and research.
We Put Patients First
Our primary focus is and always will be the needs of our patients and their physicians. We are dedicated to improving clinical practices through innovations driven by research and tested rigorously in real-world settings.
Shared Vision
As your colleagues, we build deep and meaningful partnerships centered on ensuring “Health for a better world".
Tech-Infused, Vital Support Services
Automated System-Wide Tools
Providence system-wide tools simplify access to valuable resources like the Providence Molecular Tumor Board.
AI-Based Clinical Trial Matching
We automate clinical trial searches using AI to help ensure that patients have access to the most advanced care.
Workflow-Integrated Reporting
Integrated Epic workflows simplify ordering, reporting, and alerting to save time and reduce double entry. As colleagues, your feedback guides these plug and play integrations.
Working Together We Make Providence Stronger for All
Support Providence-Driven Research
The MGL supports a wide variety of research studies, from single-cell genomic interrogation of the immune system to population-scale studies enabling better access to genomic testing.
Aligned Learning and Research Interests
We work with our colleagues across Providence to align future studies and share what we’re learning along the way.
Providence is at the forefront of bringing the promise of digital pathology to fruition. Learn how our team partnered with Microsoft to create the world’s most advanced whole-slide foundation model based on real-world data.
Comprehensive Genomic Profiling Opens Doors to More Treatment Options
Given the wealth of new precision cancer therapies gaining approval every year, we believe that tumor genomic testing should be comprehensive. We've led the way in enabling access to Comprehensive Genomic Profiling for our patients and we've have shown that this approach can make a clear impact on patient care.
By partnering with the Providence Molecular Genomics Lab, you are supporting research and innovations in fighting cancer. Providence is one of 19 cancer centers engaged in the GENIE data sharing consortium focused on ensuring access to one of the broadest and richest cancer datasets available anywhere.
“As genomic sequencing rapidly shifts into clinical practice, we are gathering evidence for widespread adoption while witnessing its transformative impact on real-life care decisions.”
Brian D. Piening PhD
Director, Providence Genomics, Providence Technical Director, Molecular Genomics Laboratory, Associate Member, Cancer Immuno-Genomics Laboratory, Earle A. Chiles Research Institute, Providence Cancer Institute
